share_log

Oracle | 4: Statement of changes in beneficial ownership of securities-Officer Screven Edward

Oracle | 4: Statement of changes in beneficial ownership of securities-Officer Screven Edward

甲骨文 | 4:持股變動聲明-高管 Screven Edward
美股SEC公告 ·  09/23 19:18

Moomoo AI 已提取核心訊息

Edward Screven, Chief Corporate Architect of Oracle Corp (ORCL), completed a stock transaction on September 20, 2024. The transaction involved the sale of 32,758 shares of Oracle's common stock at a price of $167.59 per share, resulting in a total market value of $5,489,913.22. Additionally, Screven acquired 66,070 shares through the exercise of derivative securities at no cost. After these transactions, Screven directly holds 2,730,411 shares of Oracle. A smaller, indirect transaction also occurred, where 23 shares were sold at the same price of $167.59, held indirectly by Screven's child, leaving an indirect holding of 870 shares.
Edward Screven, Chief Corporate Architect of Oracle Corp (ORCL), completed a stock transaction on September 20, 2024. The transaction involved the sale of 32,758 shares of Oracle's common stock at a price of $167.59 per share, resulting in a total market value of $5,489,913.22. Additionally, Screven acquired 66,070 shares through the exercise of derivative securities at no cost. After these transactions, Screven directly holds 2,730,411 shares of Oracle. A smaller, indirect transaction also occurred, where 23 shares were sold at the same price of $167.59, held indirectly by Screven's child, leaving an indirect holding of 870 shares.
甲骨文公司(ORCL)首席企業架構師Edward Screven於2024年9月20日完成了一筆股票交易。該交易涉及出售32,758股甲骨文普通股,每股價格爲$167.59,總市值爲$5,489,913.22。此外,Screven通過免費行使衍生證券獲得了66,070股股票。在這些交易之後,Screven直接持有甲骨文公司2730411股。另外還發生了一筆間接交易,以相同價格$167.59出售23股股票,這些股票由Screven的孩子間接持有,留下間接持有870股。
甲骨文公司(ORCL)首席企業架構師Edward Screven於2024年9月20日完成了一筆股票交易。該交易涉及出售32,758股甲骨文普通股,每股價格爲$167.59,總市值爲$5,489,913.22。此外,Screven通過免費行使衍生證券獲得了66,070股股票。在這些交易之後,Screven直接持有甲骨文公司2730411股。另外還發生了一筆間接交易,以相同價格$167.59出售23股股票,這些股票由Screven的孩子間接持有,留下間接持有870股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息